AKT2 and small cell lung carcinoma: Comprehensive genomic analyses have identified that 7–36% of SCLC harbor PTEN, PIK3CA, AKT2, AKT3, RICTOR, and MTOR mutations, suggesting the frequent dysregulation of PI3K/AKT/mTOR pathway in SCLC [39, 40].